Characterization of the transport signals that mediate the nucleocytoplasmic traffic of low risk HPV11 E7  by McKee, Courtney H. et al.
Virology 443 (2013) 113–122Contents lists available at SciVerse ScienceDirectVirology0042-68
http://d
Abbre
NES, nu
glutathi
n Corr
140 Com
E-mjournal homepage: www.elsevier.com/locate/yviroCharacterization of the transport signals that mediate
the nucleocytoplasmic trafﬁc of low risk HPV11 E7
Courtney H. McKee, Zeynep Onder, Aditya Ashok, Rebeca Cardoso, Junona Moroianu n
Biology Department, Boston College, Chestnut Hill, MA 02467, United Statesa r t i c l e i n f o
Article history:
Received 31 January 2013
Returned to author for revisions
21 March 2013
Accepted 29 April 2013
Available online 29 May 2013
Keywords:
Human papillomavirus
HPV11 E7 protein
Nuclear localization signal
Nuclear export signal
FG-nucleoporin Nup62
CRM1 nuclear export receptor22/$ - see front matter & 2013 Elsevier Inc. A
x.doi.org/10.1016/j.virol.2013.04.031
viations: HPV, human papillomavirus; NLS,
clear export signal; EGFP, enhanced green ﬂu
one-S-transferase.
espondence to: Boston College, Biology Departm
monwealth Avenue, Chestnut Hill, MA 02467,
ail address: moroianu@bc.edu (J. Moroianu).a b s t r a c t
We previously discovered that nuclear import of low risk HPV11 E7 is mediated by its zinc-binding
domain via a pathway that is independent of karyopherins/importins (Piccioli et al., 2010. Virology 407,
100–109). In this study we mapped and characterized a leucine-rich nuclear export signal (NES),
76IRQLQDLLL84, within the zinc-binding domain that mediates the nuclear export of HPV11 E7 in
a CRM1-dependent manner. We also identiﬁed a mostly hydrophobic patch 65VRLVV69 within the
zinc-binding domain that mediates nuclear import of HPV11 E7 via hydrophobic interactions with the
FG-repeats domain of Nup62. Substitutions of hydrophobic residues to alanine within the 65VRLVV69
sequence disrupt the nuclear localization of 11E7, whereas the R66A mutation has no effect. Overall the
data support a model of nuclear entry of HPV11 E7 protein via hydrophobic interactions with FG
nucleoporins at the nuclear pore complex.
& 2013 Elsevier Inc. All rights reserved.Introduction
In the United States, infection with human papillomaviruses
(HPVs) is more prevalent than all other sexually transmitted
diseases combined. HPV infection is associated with more than
99% of cervical cancers, and a high percentage of anal, perianal,
vulvar, penile and oropharyngeal cancers. Some 30 distinct HPV
genotypes preferentially infect anogenital mucosal epithelial tissues
and they demonstrate different degrees of oncogenic potential with
some classiﬁed as “high risk” types, and others as “low risk” types.
The high risk HPVs such as, types 16, 18, 31 and 45, are frequently
detected in invasive cervical carcinomas (zur Hausen, 2000). The
most common low risk HPV types, 6 and 11, cause benign anogenital
warts, or condyloma accuminata, affecting 1–2% of young adults in
many countries (Doorbar, 2006; zur Hausen, 2000, 2009).
The replication cycle of HPVs is linked to the differentiation
program of host epithelial cells with the productive viral DNA
ampliﬁcation occurring in the upper layers of the differentiated
epithelial cells. As HPVs depend on the replication machinery of the
host cells they have evolved the E7 proteins to induce reentry into
the S phase of the differentiated epithelial cells and establish thell rights reserved.
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The high risk HPV16/18 oncoproteins bind and destabilize the retino-
blastoma protein (pRB) and the RB-related pocket proteins, p130 and
p107. Interestingly, the low risk HPV E7 proteins bind pRB with
approx. ten-fold lower efﬁciency and destabilize it inefﬁciently
(McLaughlin-Drubin and Munger, 2009). Both the high risk HPV18
E7 and the low risk HPV11 E7 bind and target nuclear p130 for
degradation causing S-phase entry in the differentiated human
keratinocytes (Genovese et al., 2008).
In addition to nuclear target proteins, HPV16 E7 and HPV11 E7
have also targets in the cytoplasm, such as the microtubule-
associated N-end rule ubiqutin ligase p600 (Huh et al., 2005)
and the nuclear mitotic apparatus protein (NuMA) (Nguyen and
Munger, 2009). The E7 proteins can change the localization of
steroid receptor co-activator (SRC-1) from the nucleus to the
cytoplasm (Baldwin et al., 2006).
HPV16 E7 and HPV11 E7 are mostly nuclear when they are
expressed transiently in different cell lines including HaCaT and
U2OS (Fiedler et al., 2004; Guccione et al., 2002). We have previously
discovered that nuclear import of HPV16 E7 and HPV11 E7 is
mediated by a novel Ran-dependent pathway that is independent
of karyopherins/importins and it is mediated by their unique zinc-
binding domain located in the C-terminal domain, amino acids
39–98 (Angeline et al., 2003; Knapp et al., 2009; Piccioli et al.,
2010). The zinc-binding domain consists of two copies of CysXXCys
motifs separated by 29 amino acids. Mutagenesis of Cys residues in
each of the two CysXXCys motifs involved in zinc binding changed
the localization of the resultant EGFP-11E7 and EGFP-11cE7 to mostly
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is essential for the nuclear localization of 11E7 protein (Piccioli et al.,
2010).
Nuclear import and export take place through the nuclear pore
complexes (NPCs) that represent specialized channels spanning
the nuclear envelope. There are some 30 different proteins called
nucleoporins (Nups) that assemble to form the NPC. There are
three major classes of Nups: transmembrane Nups (Poms)
involved in anchoring the NPC at the nuclear envelope, structural
Nups, and FG-Nups, containing phenylalanine–glycine (FG)
repeats, and involved in nuclear import and export (Terry and
Wente, 2009). The mechanism of translocation through the NPC
involves low afﬁnity hydrophobic interactions between karyopher-
ins (importins and exportins) and the FG repeats in FG-Nups.
Major FG-Nups of the mammalian NPC involved in nuclear import
include Nup62 located at the central transport channel, Nup214
and Nup358 on the cytoplasmic ﬁbers and Nup153 on the
nucleoplasmic ﬁbers of the NPC (Terry and Wente, 2009).
We have previously found that HPV11 E7 and HPV16 E7,
similarly as the karyopherins/importins, can bind to phenyl-
Sepharose beads, which mimic the speciﬁcity of FG nucleoporins
at the NPC. These data support a model in which E7 proteins may
enter the nucleus via direct low afﬁnity hydrophobic interactions
with FG nucleoporins in a similar manner as the karyopherins/
importins (Piccioli et al., 2010).
In this study we continued our analysis of the nucleocyto-
plasmic transport of low risk HPV11 E7 protein. We discovered
and characterized a leucine-rich nuclear export signal (NES),
76IRQLQDLLL84, within the zinc-binding domain that mediates
nuclear export of HPV11 E7 via a CRM1 pathway. We identiﬁed a
mostly hydrophobic patch 65VRLVV69 within the zinc-binding
domain that mediates nuclear import via hydrophobic interac-
tions with the FG repeats domain of the central nucleoporin,
Nup62. Substitutions of hydrophobic residues to alanine in this
mostly hydrophobic patch 65VRLVV69 disrupt the nuclear loca-
lization of EGFP-11E7 and EGFP-11cE7, suggesting that their
nuclear import is critically dependent on these residues. These
data strongly support a model of nuclear entry of HPV11 E7
protein via hydrophobic interactions with FG nucleoporins at
the NPC.Results
The RJA nuclear export inhibitor partially restores the nuclear
localization of HPV11 E7 cysteine mutants
We have previously discovered that HPV16 E7 oncoprotein is
exported from the nucleus via a CRM1-mediated pathway
(Knapp et al., 2009). To determine if HPV11 E7 can also undergo
nuclear export we used transient transfections in HeLa cells
with plasmids containing EGFP fused to 11E7 and mutants, and
Ratjadone A (RJA), a speciﬁc nuclear export inhibitor that blocks
CRM1-mediated nuclear export of proteins containing leucine-
rich NESs. RJA inhibition functions similarly to Leptomycin B
(LMB): it covalently modiﬁes a cysteine residue in the NES-
binding pocket of CRM1 thereby inhibiting NES-binding (Hutten
and Kehlenbach, 2007; Meissner et al., 2004). We analyzed the
effect of RJA on the localization of two cysteine mutants, EGFP-
11E7C58A and EGFP-11E7C91A, which were previously determined
to have an altered cytoplasmic and pancellular localization due
to the weakening of the NLS of 11E7. In contrast, the wild type
EGFP-11E7 has a mostly nuclear localization (Piccioli et al.,
2010). As a positive control for RJA, we used EGFP-16E7-NES,
which contains a fusion of 16E7 with the strong leucine-rich NES of
HIV Rev at its C-terminus (Knapp et al., 2009). Wild type EGFP-16E7 localizes to the nucleus, and addition of the NES of Rev
changes its localization to cytoplasmic. Therefore, HeLa cells were
transfected with EGFP-11E7 wild type, EGFP-11E7C58A, EGFP-
11E7C91A, and EGFP-16E7NES plasmids and examined by confocal
microscopy 24 h post transfection. RJA treatment was performed
20 h post transfection for 4 h. Wild type EGFP-11E7 localizes
mostly to the nucleus in the absence or presence of RJA (Fig. 1A,
panels A and C), with a slight increase in the percent of cells with
nuclear localization from 80% to 90% in the presence of RJA
(Fig. 1B). As expected, RJA changed the localization of EGFP-
16E7NES from cytoplasmic to mostly nuclear in the great majority
of cells (Fig. 1A, compare panels M and O, Fig. 1B). Interestingly, RJA
also changed the localization of EGFP-11E7C58A and EGFP-11E7C91A
from cytoplasmic and pancellular to mostly nuclear (Fig. 1A,
compare panel E with G, and panel I with K). Quantitative analysis
indicated that the effect of RJA was signiﬁcant, with a change for
EGFP-11E7C91A from 90% of the cells with cytoplasmic phenotype
to 55% cells with mostly nuclear localization (and the rest of cells
with pancellular localization) in the presence of RJA (Fig. 1B). RJA
treatment also partially rescued the nuclear localization of EGFP-
11E7C58A to 55% of the cells, with the remaining cells having a
pancellular phenotype (Fig. 1B). These data suggest that HPV11 E7
can undergo CRM1-mediated nuclear export, which can be speci-
ﬁcally inhibited by RJA.
Analysis of HPV11 E7 revealed a potential leucine-rich NES
(76IRQLQDLLL84) located in the C-terminus and homologous with
the previously characterized NES of HPV16 E7 (Knapp et al., 2009).
Therefore to further analyze the nuclear export of HPV11 E7 we
examined the effect of RJA on the same two cysteine mutants in
the context of its C-terminal domain, 11cE7. HeLa cells were
transfected with EGFP-11cE7 wild type, EGFP-11cE7C58A, EGFP-
11cE7C91A, and EGFP-16E7NES plasmids and examined by confocal
microscopy 24 h post transfection. Wild type EGFP-11cE7 was
localized to the nucleus of 80% of the transfected cells in the
absence of RJA (Fig. 2A and B), and in its presence this nuclear
localization increased to 90% cells (Fig. 2A and B). RJA treatment
led to a partial recovery of the localization of EGFP-11cE7C91A
mutant with approximately 10% of the cells having a mostly
nuclear phenotype and 75% with pancellular localization in con-
trast with over 90% of cells having cytoplasmic localization in the
absence of RJA (Fig. 2A, compare panels I and K; and Fig. 2B). The
effect of RJA on the localization of EGFP-11cEC58A was more
modest as in the absence of RJA the mutant already had a
pancellular localization in 65% of the cells, with the rest exhibiting
a cytoplasmic localization, while in the presence of RJA, 15% of the
cells had a mostly nuclear phenotype and 80% had a pancellular
localization (Fig. 2B). These data suggest that HPV11 E7 has a
functional leucine-rich NES located within its C-terminal domain
whose activity can be inhibited by RJA.
HPV11 E7 has a leucine-rich NES and mutation of critical leucine
residues inhibit its nuclear export function
We have previously determined that there is a leucine-rich
NES (76IRTLEDLLM84) located within the zinc-binding domain of
HPV16 E7 oncoprotein that mediates its nuclear export in a
CRM1-dependent manner (Knapp et al., 2009). Comparison of
the sequences of HPV16 E7 NES with the homologous sequences
in other HPV types showed that the hydrophobic residues
are conserved in other HPV types, including HPV11 E7
(76IRQLQDLLL84). In order to investigate if this homologous
NES of 11E7 is functional, we mutated the leucine residues,
one at position 79 and three at positions 82–84 in the context of
EGFP-11E7C91A and EGFP-11E7C58A mutants and analyzed the
localization of these double mutants 24 h post-transfection in
HeLa cells. The localization of both EGFP-11E7C91A/L79A and
Fig. 1. (A) The RJA nuclear export inhibitor partially restores the nuclear localization of EGFP-11E7 C58A and C91A mutants. HeLa cells were transfected with either EGFP-
11E7 wild type (panels A–D), EGFP-11E7C58A (panels E–H), EGFP-11E7C91A (panels I–L), and EGFP-16E7NES (panels M–P) plasmids in the absence (−RJA) or in the presence of
RJA (+RJA) and examined by confocal ﬂuorescence microscopy at 24 h post-transfection. Panels A, C, E, G, I, K, M, and O represent the ﬂuorescence of the EGFP and panels B,
D, F, H, J, L, N, and P the DAPI staining of the nuclei. (B) Quantitative analysis of the effect of RJA on the localization of the EGFP-11E7 C58A and C91A mutants. The data from
four experiments using EGFP-11E7, EGFP-11E7C58A, EGFP-11E7C91A, and EGFP-16E7NES plasmids, with or without RJA treatment, have been used for the quantitative analysis
and the graphic representation. Mostly nuclear, black bars; pancellular, gray bars; cytoplasmic, dotted bars.
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parison with that of EGFP-11E7C91A, which had a cytoplasmic
localization in 90% of the transfected cells (Fig. 3A, panels D andF, and Fig. 3B). The EGFP-11E7C91A/L79A had a mostly nuclear
phenotype in some 20% of the cells and pancellular localization
in approximately 75% of the cells (Fig. 3A, panels G and I, and
Fig. 2. (A) The RJA nuclear export inhibitor partially restores the nuclear localization of EGFP-11cE7 C58A and C91A mutants. HeLa cells were transfected with either EGFP-
11cE7 wild type (panels A–D), EGFP-11cE7C58A (panels E–H), EGFP-11cE7C91A (panels I–L), and EGFP-16E7NES (panels M–P) plasmids in the absence (−RJA) or in the presence
of RJA (+RJA) and examined by confocal ﬂuorescence microscopy at 24 h post transfection. Panels A, C, E, G, I, K, M, and O represent the ﬂuorescence of the EGFP and panels
B, D, F, H, J, L, N, and P the DAPI staining of the nuclei. (B) Quantitative analysis of the effect of RJA on the localization of EGFP-11cE7 C58A and C91A mutants. The data from
six experiments using EGFP-11cE7, EGFP-11cE7C58A, EGFP-16E7NES plasmids, and four experiments using EGFP-11cE7C91A plasmid, with or without RJA treatment, have been
used for the quantitative analysis and the graphic representation. Mostly nuclear, black bars; pancellular, gray bars; cytoplasmic, dotted bars.
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nuclear localization in 20% of the cells and pancellular localiza-
tion in approximately 75% of the cells (Fig. 3A, panels J and L,
and Fig. 3B).The localization of EGFP-11E7C58A/L79A and EGFP-11E7C58A/82LLL/
AAA double mutants was also changed in comparison with the
EGFP-11E7C58A single mutant (Fig. 3C). However, the effect of the
leucine mutations on localization was more modest as EGFP-
Fig. 3. (A) Substitutions of critical leucine residues to alanine in a potential cNES change the localization of the EGFP-11E7 C91A mutant. HeLa cells were transfected with
either EGFP-11E7 wild type (panels A–C), EGFP-11E7C91A (panels D–F), EGFP-11E7C91A/L79A (panels G–I), and EGFP-11E7C91A/82LLL/AAA (panels J–L) plasmids and examined by
confocal ﬂuorescence microscopy at 24 h post transfection. Panels A, D, G, and J represent the ﬂuorescence of the EGFP; panels B, E, H, and K the DAPI staining of the nuclei,
and panels C, F, I and L the MERGE. (B) Quantitative analysis of the effect of mutations of critical leucine residues in the cNES on the localization of the EGFP-11E7 C91A
mutant. The data from four experiments using EGFP-11E7, EGFP-11E7C91A, EGFP-11E7C91A/L79A, and EGFP-11E7C91A/82LLL/AAA plasmids have been used for the quantitative
analysis and the graphic representation. Mostly nuclear, black bars; pancellular, gray bars; cytoplasmic, dotted bars. (C) Quantitative analysis of the effect of mutations of
critical leucine residues in a potential cNES on the localization of the EGFP-11E7 C58A mutant. The data from four experiments using EGFP-11E7, EGFP-11E7C58A, EGFP-
11E7C58A/L79A, and EGFP-11E7C58A/82LLL/AAA plasmids have been used for the quantitative analysis and the graphic representation. Mostly nuclear, black bars; pancellular, gray
bars; cytoplasmic, dotted bars.
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70% of the cells and a cytoplasmic localization in only 30% of the
cells (Fig. 3C). The EGFP-11E7C58A/L79A double mutant was localized
to the nucleus in some 20% of the cells and throughout the cell
(pancellular) in approximately 75% of the cells (Fig. 3C). EGFP-
11E7C58A/82LLL/AAA was nuclear in some 10% of the cells and
pancellular in approximately 85% cells (Fig. 3C). An immunoblot
analysis of the expressed EGFP-11E7 and mutants showed that all
the fusion proteins were expressed at similar levels and were not
degraded (data not shown).
Overall, analysis of the localization of the 11E7 double mutants
containing mutations of leucine residues in the NES suggests that
the 76IRQLQDLLL84 sequence is indeed a functional NES for 11E7,
mediating its nuclear export.HPV11 E7 interacts with CRM1 nuclear export receptor
The identiﬁcation of a functional leucine-rich NES mediating
11E7 nuclear export prompted us to analyze the interaction of
11E7 with CRM1 nuclear export receptor. HeLa cell lysates
containing EGFP-11cE7, EGFP-16E7NES (as a positive control),
or EGFP (as a negative control) were incubated with GST-CRM1
or GST immobilized on glutathione-Sepharose beads and the
bound proteins were analyzed by immunobloting with a GFP
antibody. As expected, EGFP-16E7NES bound to GST-CRM1 and
not to GST itself (Fig. 4, lanes 2, 5 and 8); EGFP did not bind to
either one (Fig. 4, lanes 3, 6 and 9). Interestingly, EGFP-11cE7
also bound to GST-CRM1 and not to GST itself (Fig. 4, lanes 1,
4 and 7). These data indicate that 11E7 interacts with CRM1
Fig. 4. HPV11 cE7 interacts with CRM1 nuclear export receptor. HeLa cells were
transfected with EGFP-11cE7, EGFP-16E7NES or EGFP and the cell lysates were
prepared 24 h post-transfection, subjected to SDS-PAGE and transfer to nitrocellu-
lose and the blots probed with GFP antibody (lanes 1, 2 and 3). GST-CRM1 (lanes 4–
6) and GST (lanes 7–9) immobilized on glutathione-Sepharose were incubated with
the cell lysates and the bound proteins were eluted, subjected to SDS-PAGE and
transfer to nitrocellulose and analyzed by immunobloting with a GFP antibody
(EGFP-11cE7, lanes 4 and 7; EGFP-16E7NES, lanes 5 and 8; EGFP, lanes 6 and 9).
Fig. 5. HPV11 E7 interacts via its zinc-binding domain with the FG domain of
Nup62. HeLa cells were transfected with EGFP-11E7, EGFP-11cE7, and EGFP and the
cell lysates were prepared 24 h post-transfection and probed with GFP antibody
(lane 1, EGFP-11E7; lane 2, EGFP-11cE7; lane 3, EGFP). HeLa cells lysate was also
probed for Kap β2 (lane 4). GST-Nup62N (lanes 5–7), GST-Nup62C (lanes 9–11) and
GST (lanes 13–15) immobilized on glutathione-Sepharose were incubated with the
cell lysates and the bound proteins were eluted and analyzed by immunobloting
with a GFP antibody (lanes 5, 9 and 13, EGFP-11E7; lanes 6, 10 and 14, EGFP-11cE7;
lanes 7, 11 and15, EGFP). As a positive control, binding of Kap β2 to GST-Nup62N,
GST-Nup62C and GST was also analyzed (lanes 8, 12 and 16).
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terminal domain (11cE7).
HPV11 E7 interacts with the FG nucleoporin Nup62
We have previously determined that HPV11 E7 enters the
nucleus via a pathway mediated by its zinc-binding domain that
is independent of karyopherins/importins (Piccioli et al., 2010).
Moreover, previous phenyl-Sepharose binding results showed that
11E7 and 11cE7 can bind to phenyl-Sepharose (Piccioli et al., 2010),
which mimics the speciﬁcity of FG repeats of nucleoporins and
binds all the karyopherins (importins and exportins) (Ribbeck and
Gorlich, 2002). These data suggested that 11E7 may be imported
into the nucleus via low afﬁnity hydrophobic interactions with the
FG-nucleoporins at the NPC in a similar way as the karyopherins.
To examine this hypothesis we chose the FG nucleoporin Nup62
that has been shown to interact with karyopherins and has a
central location at the transport channel of the NPC (Solmaz et al.,
2011). In these experiments we used Nup62N, containing the FG
domain of Nup62 with six FG repeats, and Nup62C, representing
the C-terminal domain of Nup62 lacking any FG repeats. Therefore,
HeLa cell lysates containing EGFP-11E7, EGFP-11cE7, and EGFP
(negative control) were incubated with GST-Nup62N, GST-Nup62C,
or GST (negative control) immobilized on glutathione-Sepharose and
the bound proteins were analyzed by immunobloting with a GFP
antibody. As a positive control, we analyzed the binding of Kap β2/
transportin nuclear import receptor to GST-Nup62N. As expected Kap
β2 bound to GST-Nup62N, and not to GST-Nup62C or GST itself
(Fig. 5, lanes 8, 12 and 16). Signiﬁcantly, both EGFP-11E7 and EGFP-
11cE7 bound to GST-Nup62N (Fig. 5, lanes 5 and 6) and not to the
GST itself (Fig. 5, lanes 13 and 14). Moreover, EGFP-11E7 and EGFP-
11cE7 did not bind to GST-Nup62C (Fig. 5, lanes 9 and 10). EGFP did
not bind either to GST-Nup62N, GST-Nup62C or GST itself (Fig. 5,
lanes 7, 11 and 15). These data indicate that HPV11 E7 protein can
bind speciﬁcally to the FG-repeats domain of Nup62 via its zinc-
binding domain.
Identiﬁcation of a patch of hydrophobic residues required for the
nuclear localization of HPV11 E7
The surface hydrophobicity of nuclear import receptors is
sufﬁcient to provide access to the NPC and the translocation
process involves non-speciﬁc interactions between small hydro-
phobic patches on the surface of the receptors/karyopherins andthe FG repeats in nucleoporins (Naim et al., 2009). Signiﬁcantly,
11cE7 domain is very rich in nonpolar, hydrophobic residues, with
some of them arranged in hydrophobic patches, which could
mediate the low afﬁnity hydrophobic interactions with the FG-
nucleoporins at the NPC. We identiﬁed a mostly hydrophobic
patch in the 11E7 zinc binding domain, 65VRLVV69, and replaced all
ﬁve residues with alanines in the context of EGFP-11E7 and EGFP-
11cE7. We also generated two single mutants by substituting the
arginine at position 66 with alanine in the context of EGFP-11E7
and EGFP-11cE7. HeLa cells were transfected with the wild type
EGFP-11E7 and EGFP-11cE7 and the mutant plasmids and the
localization of all the expressed proteins was analyzed by confocal
ﬂuorescence microscopy. As expected EGFP-11E7 and EGFP-11cE7
had a mostly nuclear localization in the great majority of cells
(Fig. 6A and B), whereas EGFP itself had pancellular localization
(Fig. 6B). Signiﬁcantly, both the EGFP-11E7VRLVV/AAAAA and EGFP-
11cE7VRLVV/AAAAA mutant had a mostly cytoplasmic localization in
approximately 97% cells (Fig. 6A and B). In contrast, both the EGFP-
11E7R66A and EGFP-11cE7R66A mutants were mostly in the nucleus
in approximately 98% of the cells (Fig. 6A and B). These data
strongly suggest that the hydrophobic residues are essential for
the nuclear localization of 11E7 and 11cE7 whereas the positively
charged arginine residue does not play any role in this process.
Signiﬁcantly, the VRLVV/AAAAA mutation that disrupted the
nuclear localization also inhibited the interaction of EGFP-11E7
and EGFP-11cE7 with the FG domain of Nup62 (Fig. 6C, compare
lane 7 with 8, and lane 9 with 10). The positive binding control,
Kap β2 bound to GST-Nup62N and not to GST itself (Fig. 6C, lanes
12 and 18), whereas EGFP did not bind to either one (Fig. 6C, lanes
11 and 18). In contrast, the R66A mutation did not affect the
interaction of EGFP-11E7 and EGFP-11cE7 with the FG domain of
Nup62 (data not shown). This is in agreement with the localization
data showing that the R66A mutation did not affect the nuclear
localization of EGFP-11E7 and EGFP-11cE7 (Fig. 6A and B). Overall,
the data strongly suggest that the hydrophobic residues in the
VRLVV sequence play an essential role in the hydrophobic inter-
action of the zinc-binding domain with the FG domain of Nup62
leading to nuclear import of 11E7.
Signiﬁcantly, this hydrophobic patch is conserved in the E7
proteins of many other HPVs including mucosal and cutaneous,
high and low risk types. Interestingly, HPV6 E7 containing the
L67R mutation within its LRLCV hydrophobic sequence binds p130
in vitro, but loses its ability to target p130 for degradation and to
decrease/delay differentiation in vivo (Zhang et al., 2006). We
Fig. 6. (A) Mutations of hydrophobic residues within the zinc-binding domain disrupt the nuclear localization of EGFP-11E7 and EGFP-11cE7. HeLa cells were transfected
with EGFP-11E7 (panels A, D and G), EGFP-11E7VRLVV/AAAAA (panels B, E and H), or EGFP-11E7R66A (panels C, F and I) plasmids, and the localization of the expressed proteins
was analyzed by confocal ﬂuorescence microscopy. Panels A, B and C represent the ﬂuorescence of the EGFP and panels D, E, and F the DAPI staining of the nuclei, and panels
G, H and I the MERGE. (B) Quantitative analysis showing that mutations of hydrophobic residues disrupt the nuclear localization of 11E7 and 11cE7. The data from four
experiments using EGFP-11E7, EGFP-11E7VRLVV/AAAAA, EGFP-11E7R66A, EGFP-11cE7, EGFP-11cE7VRLVV/AAAAA, EGFP-11cE7R66A and EGFP plasmids have been used for the
quantitative analysis and the graphic representation. Mostly nuclear, black bars; pancellular, gray bars; cytoplasmic, dotted bars. (C) Mutations of hydrophobic residues
inhibit the interaction of 11E7 and 11cE7 with the FG domain of Nup62. HeLa cells were transfected with EGFP-11E7 (lane 1), EGFP-11E7VRLVV/AAAAA (lane 2), EGFP-11cE7 (lane
3), EGFP-11cE7VRLVV/AAAAA (lane 4), and EGFP (lane 5) and the cell lysates were prepared 24 h post-transfection and probed with a GFP antibody. HeLa cells lysate was also
probed for Kap β2 (lane 6). GST-Nup62N (lanes 7–11) and GST (lanes 13–17) immobilized on glutathione-Sepharose were incubated with the cell lysates and the bound
proteins were eluted and analyzed by immunobloting with a GFP antibody (lane 7, EGFP-11E7; lane 8, EGFP-11E7VRLVV/AAAAA; lane 9, EGFP-11cE7; lane 10, EGFP-11cE7VRLVV/
AAAAA; lane 11, EGFP). As a positive control, binding of Kap β2 to GST-Nup62N and GST was also analyzed (lanes 12 and 18).
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analyzed their localization in comparison with the wild type
proteins. We found that both EGFP-11E7L67R and EGFP-11cE7L67Rmutants had a predominantly cytoplasmic localization (Fig. 7,
panels B and J, and panels D and L) in the majority of cells
(90.7271.85%, and 81.671.23%, respectively) with the rest of
Fig. 7. The L67R mutation disrupts the nuclear localization of EGFP-11E7 and EGFP-11cE7. HeLa cells were transfected with EGFP-11E7 (panels A, E and I), EGFP-11E7L67R
(panels B, F and J), EGFP-11cE7 (panels C, G and K), or EGFP-11cE7L67R (panels D, H and L) plasmids, and the localization of the expressed proteins was analyzed by confocal
ﬂuorescence microscopy. Panels A–D represent the ﬂuorescence of the EGFP, panels E–H the DAPI staining of the nuclei, and panels I–L the MERGE.
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contrast with the mostly nuclear localization of the wild type
proteins (Fig. 7, panels A and I, and panels C and K). These data
indicate that the hydrophobic leucine 67 residue is essential for
the nuclear import and localization of 11E7, and its substitution
with a positively charged arginine residue disrupts 11E7 nuclear
import.Discussion
In this study we continued our analysis of the nucleocytoplas-
mic trafﬁc of low risk HPV11 E7 protein. We mapped and
characterized a leucine-rich NES in the C terminal domain of low
risk HPV11 E7 protein (76IRQLQDLLL84), which has a high degree of
homology with the previously characterized NES sequence of
HPV16 E7, 76IRTLEDLLM84 (Knapp et al., 2009). Changing critical
leucine residues at position 79 or 82–84 to alanine inhibited the
nuclear export activity of this HPV11 E7 NES. As the wild type
HPV11 E7 exhibits a nuclear localization, these NES mutations
were introduced in the context of two previously characterized
zinc-binding deﬁcient mutants, C58A and C91A, that have cyto-
plasmic and pancellular localization, due to weakening of the NLS
of HPV11 E7 protein (Piccioli et al., 2010). Addition of the
secondary NES mutations partially rescued the nuclear phenotype
of the zinc-binding deﬁcient mutants by inhibition of their nuclear
export. The nuclear rescue did not reach the wild type level and
this most likely is due to the weakening of nuclear import by the
C58A and C91A mutations.
The cNES of HPV11 E7 mediates its nuclear export in a CRM1-
dependent manner, being speciﬁcally inhibited by the RJA nuclearexport inhibitor. Moreover, we determined that HPV11 E7 interacts
with CRM1 nuclear export receptor via its cNES located in the
C-terminal domain, 11cE7. We obtained similar results for the
interaction between the cNES of 16cE7 and CRM1 (data not
shown).
Overall, the data suggest that HPV11 E7 like HPV16 E7 shuttles
between the nucleus and cytoplasm, which would be expected
from their functions, as these E7 proteins have cellular targets
both in the nucleus and in the cytoplasm. The different interac-
tions of E7 proteins with their nuclear and cytoplasmic targets
could modulate their nucleocytoplasmic trafﬁc and consequently
their steady-state intracellular localization in different physiologi-
cal conditions and during the viral cycle. Interestingly, the balance
between nuclear import and nuclear export of wild type HPV11
cE7 favors nuclear localization, whereas for HPV16 cE7 it favors
cytoplasmic localization (Knapp et al., 2009; Piccioli et al., 2010).
We have previously established that the zinc-binding domain
of HPV11 E7 mediates its nuclear import via a pathway indepen-
dent of karyopherins/importins and suggested that this pathway
may involve hydrophobic interactions between the zinc-binding
domain and FG nucleoporins (Piccioli et al., 2010). In this study we
found that HPV11 E7 indeed interacts via its zinc-binding domain
with the FG domain (containing six FG repeats) of Nup62, a
nucleoporin located in the midplane of the nuclear pore complex
and involved in nuclear import and export (Solmaz et al., 2011).
Moreover, we identiﬁed a mostly hydrophobic patch 65VRLVV69
within the zinc-binding domain that is essential for the nuclear
localization of 11E7 and 11cE7. Mutations of the hydrophobic
residues to alanine completely disrupted the nuclear localization
and the EGFP-11E7VRLVV/AAAAA and EGFP-11cE7VRLVV/AAAAA mutants
had cytoplasmic localization. In contrast, the R66A mutation did
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11cE7R66A, indicating that this positively charged residue does not
play any role in nuclear import of HPV11 E7. Signiﬁcantly, the
VRLVV/AAAAA mutations inhibited the interaction of both 11E7
and 11cE7 with the FG domain of Nup62, suggesting that the
hydrophobic residues in this sequence play a key role in the
hydrophobic interaction of the zinc-binding domain with Nup62.
This inhibitory effect correlated very well with the complete
disruption of the nuclear localization of EGFP-11E7 and EGFP-
11cE7. Overall, these data strongly suggest that low risk HPV11 E7
is imported into the nucleus via hydrophobic interactions of its
zinc-binding domain with the FG domain of Nup62 at the nuclear
pore complex. It is likely that HPV11 E7 may interact with other FG
nucleoporins at the NPC, like Nup153 and Nup358. Preliminary
data suggest that HPV11 E7 indeed binds via its zinc-binding
domain to Nup153.
The mechanism of nuclear import of low risk HPV11 E7 via
hydrophobic interactions of its zinc-binding domain with the FG
domain of Nup62 is conserved with that of the high risk HPV16 E7
oncoprotein (manuscript in preparation). Signiﬁcantly, we have
found that the homologous hydrophobic sequences in HPV16 E7
and HPV8 E7, LRLCV and LRLFV, are also essential for the nuclear
import of these E7 proteins, and mutation of the hydrophobic
residues to alanine inhibit both nuclear import and the interaction
with Nup62N (in preparation). Interestingly, the HPV6 E7L67R
mutant, although it binds p130 in vitro, it loses its ability to target
p130 for degradation and to decrease/delay differentiation (Zhang
et al., 2006). As we found that the L67R mutation disrupts the
nuclear localization of 11E7, it can be speculated that nuclear
localization of HPV6 E7 may be required for its ability to target
p130 for degradation in vivo (Zhang et al., 2006).
This mechanism of nuclear import of HPV E7 proteins via direct
hydrophobic interactions of their zinc-binding domain with FG
nucleoporins is unique in comparison with other HPV proteins like
L1 and L2 capsid proteins and E6 oncoprotein, that use different
karyopherins/importins to enter the nucleus (Bordeaux et al.,
2006; Darshan et al., 2004; Klucevsek et al., 2006; Le Roux and
Moroianu, 2003; Nelson et al., 2002).
The TAX protein of human T lymphotropic virus type 1 also
enters the nucleus via direct hydrophobic interactions of its zinc-
binding domain with the FG nucleoporin Nup62 at the nuclear
pore complex (Tsuji et al., 2007). Moreover, mutations in the zinc-
binding domain that block the nuclear import and localization of
TAX also inhibit its interaction with Nup62 (Tsuji et al., 2007).
There are also cellular proteins like PU.1 transcription factor, that
enter the nucleus via a pathway independent of karyopherins,
mediated by direct binding to the FG-nucleoporins Nup62 and
Nup153 (Zhong et al., 2005).Materials and methods
Mutagenesis to generate different EGFP-11E7 and EGFP-11cE7
mutants
EGFP-11E7 and EGFP-11cE7 wild type, and EGFP-11E7C58A, EGFP-
11E7C91A, EGFP-11cE7C58A, EGFP-11cE7C91A mutant plasmids were
obtained previously (Piccioli et al., 2010). The EGFP-11E7C58A/L79A
and EGFP-11E7C58A/82LLL/AAA, EGFP-11E7C91A/L79A and EGFP-11E7C91A/
82LLL/AAA double mutants were generated using the Quik-
Change™ Site-Directed Mutagenesis Kit (Stratagene) with EGFP-
11E7C58A and EGFP-11E7C91A as templates and corresponding muta-
genesis primers for the substitutions in the NES.
The EGFP-11E7VRLVV/AAAAA, EGFP-11cE7VRLVV/AAAAA, EGFP-11E7R66A,
EGFP-11cE7R66A, EGFP-11E7L67R and EGFP-11cE7L67R mutant plasmids
were generated using the QuikChange™ Site-Directed MutagenesisKit (Stratagene) with EGFP-11E7 and EGFP-11cE7 as templates and
the corresponding mutagenesis primers.
The mutant plasmids were transformed into XL1-blue compe-
tent cells and extracted using Quantum PrepR Plasmid MiniPrep kit
(BioRad). All puriﬁed mutant plasmids were checked by sequen-
cing (Euroﬁns MWG) and maintained in stock cultures at −80 1C
before use in transfection experiments.
Transient expression of EGFP fusion proteins and confocal microscopy
analysis
HeLa cells (ATCC) were plated on 12 mm poly-L-lysine-coated
glass coverslips to 50% conﬂuency 24 h prior to transfection. Cells
in each well were transfected with the corresponding EGFP fusion
plasmid (as indicated in the ﬁgure legends) and the FuGENE
6 reagent (Roche Applied Science, IN). Media was changed to
DMEM with 10% FBS and 1% penicillin–streptomycin after 6 h and
the cells were ﬁxed 24 h after the initial transfection with 3.7%
formaldehyde in PBS (10 min). Coverslips were mounted using
Vectashield-DAPI mounting medium (Vector Labs, CA) to visualize
the nuclei by DAPI staining. The slides were examined by ﬂuores-
cence microscopy using a Leica TCS Sp5 broadband confocal
microscope and pictures were taken using the Leica LAS AF
software (Leica Microsystems).
Quantiﬁcation of the intracellular localization phenotypes of
the different EGFP-11E7 and EGFP-11cE7 proteins deﬁned as
mostly nuclear, pancellular or mostly cytoplasmic was performed
on all the transfection experiments. The data from at least four
experiments were used for the quantitative analysis and the
graphical representations display average values with standard
deviation.
Immunoblot analysis of the expressed EGFP-11E7, EGFP-11cE7
and different mutants performed with a GFP antibody indicated
that the proteins were expressed at similar levels and not degraded.
Ratjadone A treatment of transfected cells
A 10 ng/ml solution of Ratjadone A (RJA) in DMEM+ was added
to the transfected cells 20 h post transfection for 4 h. A parallel
transfection received no RJA treatment, only fresh DMEM+ at 20 h
post transfection for 4 h. Cells were then ﬁxed and the localization
of different EGFP fusion proteins analyzed as described above. The
experiments presented in the ﬁgures and used for the quantitation
analysis were performed in parallel.
Preparation of GST-CRM1, GST-Nup62N and GST-Nup62C
The GST-CRM1 plasmid was kindly provided by Dr. Jorgen
Kjems and the GST-Nup62N (containing aa 1–265 of Nup62) and
GST-Nup62C (containing aa 178–522 of Nup62) plasmids (Zhong
et al., 2005) were kindly provided Dr. Nabeel Yaseen. For protein
expression and puriﬁcation the GST-CRM1, GST-Nup62N and GST-
Nup62C plasmids were used to transform E. coli BL21 CodonPlus.
After induction of the bacteria with 1 mM IPTG for 3 h the GST-
fusion proteins were puriﬁed in their native state on Glutathione-
Sepharose beads using a standard procedure.
Binding assays
Before the binding assays GST-CRM1 and GST immobilized on
glutathione- Sepharose beads were analyzed by SDS-PAGE and
Coomassie staining. This analysis showed that the proteins were
intact and bound to the beads at similar levels. HeLa cell lysates
containing the expressed EGFP-11cE7, EGFP-16E7NES (as a positive
control), or EGFP (as a negative control) and 1 mM GTP-γs were
incubated with either GST-CRM1 or GST immobilized on
C.H. McKee et al. / Virology 443 (2013) 113–122122glutathione-Sepharose beads for 1 h at 4 1C. After washing the
beads to remove nonspeciﬁc binding the bound proteins were
eluted with SDS-sample buffer, subjected to SDS-PAGE and ana-
lyzed by immunobloting with a GFP antibody.
Before the binding assays GST-Nup62N, GST-Nup62C and GST
immobilized on glutathione-Sepharose were analyzed by SDS-
PAGE and Coomassie staining. This analysis revealed for GST-
Nup62N and GST-Nup62C the presence of the intact proteins
bound at similar levels to the beads, and also some degradation.
HeLa cell lysates containing the expressed EGFP-11E7, EGFP-11cE7,
and EGFP (negative control) were incubated with GST-Nup62N
(containing the FG domain of Nup62), GST-Nup62C (lacking FG
repeats) or with GST immobilized on glutathione-Sepharose for
1 h at 4 1C. After washing the beads to remove nonspeciﬁc binding
the bound proteins were analyzed by immunobloting with a GFP
antibody. As a positive control for binding to Nup62N, we analyzed
the binding of Kap β2/transportin nuclear import receptor to
GST-Nup62N by incubating HeLa cell lysate with GST-Nup62N,
GST-Nup62C or GST and the bound proteins were analyzed by
immunobloting with a Kap β2 antibody.Acknowledgments
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